Effects of elagolix on the pharmacokinetics of omeprazole and its metabolites in healthy premenopausal women
Abstract This study evaluated the effect of repeated doses of elagolix on the pharmacokinetics (PK) of omeprazole and its metabolites in healthy premenopausal female subjects. Adult premenopausal female subjects (N = 20) received a single oral dose of omeprazole (40 mg) on day 1 and day 11 and oral...
Saved in:
Main Authors: | Ahmed Nader (Author), Nael M. Mostafa (Author), Elaine Kim (Author), Mohamad Shebley (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Validation of a quantitative systems pharmacology model of calcium homeostasis using elagolix Phase 3 clinical trial data in women with endometriosis
by: Sven Stodtmann, et al.
Published: (2021) -
Effect of Elagolix Exposure on Clinical Efficacy End Points in Phase III Trials in Women With Endometriosis‐Associated Pain: An Application of Markov Model
by: Insa Winzenborg, et al.
Published: (2020) -
Exposure‐Safety Analyses Identify Predictors of Change in Bone Mineral Density and Support Elagolix Labeling for Endometriosis‐Associated Pain
by: Ahmed Abbas Suleiman, et al.
Published: (2020) -
Integrating real‐world data and modeling to project changes in femoral neck bone mineral density and fracture risk in premenopausal women
by: Denise Beck, et al.
Published: (2021) -
Phase 2, double-blind, randomized, placebo-controlled study of the safety and efficacy of elagolix in women with polycystic ovary syndrome
by: Michael C. Snabes, M.D., Ph.D, et al.
Published: (2023)